Why Support CHOP

Hope on the horizon for children with sickle cell disease

Millions of people worldwide — including more than 100,000 in the United States — are affected by sickle cell disease and have an increased risk of painful episodes, infection, and organ damage. The disease occurs in one in 500 African Americans, and one in 1,000-1,400 Hispanic Americans.Though a diagnosis of sickle cell disease is a devastating blow to families, there is hope for children with the disorder at The Comprehensive Sickle Cell Center at The Children’s Hospital of Philadelphia.

The Center is one of the largest of its kind in the nation, caring for more than 1,000 patients a year. Under the leadership of Director Kim Smith-Whitley, MD, the Center strives to reduce the devastating effects of sickle cell disease.

The Comprehensive Sickle Cell Center has pioneered research in treatment of children with sickle cell disease, developing a stem cell transplant procedure that gives real hope for a “universal cure,” along with other groundbreaking research into treatments and cures, including:

  • Studying gene therapy options for those currently battling sickle cell disease
  • Investigating how DNA physically interacts with itself and other proteins to activate genes to produce fetal hemoglobin, potentially reversing the effects of the disease
  • Curing sickle cell disease through in utero stem cell transplantation

By supporting the Blue Tag Gala, you are helping speed research and allowing the Comprehensive Sickle Cell Center to expand and enhance treatments for patients and families.